| Name | Description | SBIR/STTR Award Recipient | Government Agency | Government Branch | Award Type | Contract Number (US Government) | Award Phase | Award Amount (USD) | Date Awarded | Official Website | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| A STTR Phase II contract was awarded to Chicago Biosolutions, Inc. in May, 2022 for $999,369.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | STTR | 4R42AI155039-02 | Phase II | 999,369 | May 5, 2022 | |||||||
| A STTR Phase I contract was awarded to Chicago Biosolutions, Inc. in April, 2021 for $300,000.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | STTR | 1R42AI155039-01A1 | Phase I | 300,000 | April 2, 2021 | |||||||
| A STTR Phase I contract was awarded to Chicago Biosolutions, Inc. in April, 2019 for $299,999.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | STTR | 1R41AI145727-01 | Phase I | 299,999 | April 1, 2019 | |||||||
| A STTR Phase II contract was awarded to Chicago Biosolutions, Inc. in August, 2019 for $972,475.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | STTR | 2R42AI126971-03A1 | Phase II | 972,475 | August 16, 2019 | |||||||
| A STTR Phase I contract was awarded to Chicago Biosolutions, Inc. in January, 2021 for $299,595.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | STTR | 1R41AI157095-01 | Phase I | 299,595 | January 11, 2021 | |||||||
| A STTR Phase I contract was awarded to Chicago Biosolutions, Inc. in June, 2016 for $396,096.0 USD from the U.S. Department of Health & Human Services. | STTR | 1R41AI127031-01 | Phase I | 396,096 | June 1, 2016 | |||||||
| A STTR Phase I contract was awarded to Chicago Biosolutions, Inc. in August, 2016 for $727,199.0 USD from the U.S. Department of Health & Human Services. | STTR | 1R41AI126971-01 | Phase I | 727,199 | August 1, 2016 | |||||||
| A SBIR Phase I contract was awarded to Chicago Biosolutions, Inc. in September, 2016 for $225,000.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43CK000495-01 | Phase I | 225,000 | September 30, 2016 |